Why the study?
Adverse pregnancy outcomes are associated with elevated CVD risk, but data regarding their occurrence in the context of pre-existing CVD risk factors and in diverse populations are limited.
What is the prevalence of adverse pregnancy outcomes among individuals with and without prepregnancy CVD risk factors in a diverse safety-net hospital population?
What is the prevalence of adverse pregnancy outcomes among individuals with and without prepregnancy CVD risk factors in a diverse safety-net hospital population?
Adverse pregnancy outcomes occur in nearly one-third of parous individuals without traditional prepregnancy CVD risk factors, highlighting a potentially missed group with elevated future CVD risk.
Answers are grounded in this paper and cite their sources.
APOs occur frequently even without prepregnancy CVD risks; leaves open whether prepregnancy screening improves outcomes in diverse safety-net populations.
Background: Many adverse pregnancy outcomes (APOs) are associated with elevated cardiovascular disease (CVD) risk. However, APO data in the context of pre-existing CVD risk factors, and from diverse populations, are limited. We assessed the occurrence of APOs among individuals with and without prepregnancy CVD risk factors, overall and by race/ethnicity. Methods: We conducted a retrospective study using electronic medical record data from a large urban safety-net hospital. Individuals with prenatal care and delivery between 2016 and 2018 at the hospital were included, and data from prenatal intake through the delivery hospitalization were captured. The exposure, prepregnancy CVD risk factors (hypertension, diabetes, tobacco use, and obesity), and the outcome, APOs (hypertensive disorders of pregnancy, gestational diabetes, preterm delivery, low birth weight, and stillbirth), were identified from electronic medical records. Results: We identified 3760 unique delivering individuals, of whom 55.1% self-identified as Black non-Hispanic and 17% as Hispanic. Prepregnancy CVD risk factor prevalence was 45.6%, most commonly obesity (26.6%). APO prevalence was 35.6%, most commonly a hypertensive disorder of pregnancy (20.1%). Overall, 45.7% of APOs occurred in the absence of recognized prepregnancy CVD risk factors, representing 16.3% of the total sample. Among individuals without prepregnancy CVD risk factors, APO prevalence was 30.0% and did not vary by race/ethnicity. Conclusions: In this racially and ethnically diverse hospital-based sample, APOs were present in one in three parous individuals without prepregnancy CVD risk factors—a group with potentially elevated CVD risk who might otherwise be missed by traditional CVD risk factor screening.
No takes yet. Share an insight, caveat, or question.
Horwitz et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: